Channelopathies Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
TVTX | B | Travere Therapeutics, Inc. | 0.40 | |
CRBP | F | Corbus Pharmaceuticals Holdings, Inc. | 6.02 |
Related Industries: Biotechnology Drug Manufacturers - Major
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | A | BioShares Biotechnology Products Fund | 3.71 | |
PTH | D | Invesco DWA Healthcare Momentum ETF | 1.11 | |
FFTY | B | Innovator IBD 50 Fund ETF | 0.98 | |
FSCC | D | Trust Federated Hermes MDT Small Cap Core ETF | 0.78 | |
DWAS | B | PowerShares DWA SmallCap Technical Leaders Portfolio | 0.45 |
Compare ETFs
- Channelopathies
Channelopathies are diseases caused by disturbed function of ion channel subunits or the proteins that regulate them. These diseases may be either congenital (often resulting from a mutation or mutations in the encoding genes) or acquired (often resulting from autoimmune attack on an ion channel).
There are a large number of distinct dysfunctions known to be caused by ion channel mutations. The genes for the construction of ion channels are highly conserved amongst mammals and one condition, hyperkalemic periodic paralysis, was first identified in the descendants of Impressive, a registered Quarter Horse.
The channelopathies of human skeletal muscle include hyper- and hypokalemic (high and low potassium blood concentrations) periodic paralysis, myotonia congenita and paramyotonia congenita.
Channelopathies affecting synaptic function are a type of synaptopathy.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles